Callan JMB and Alabama State University Announce Strategic Partnership to Advance U.S. Pharmaceutical Manufacturing and Supply Chain Resilience
Management believes the initiative could represent a potential $414 million five-year revenue opportunity for Callan JMB while helping establish a next-generation pharmaceutical manufacturing ecosystem in the United States.
Management believes the initiative could represent a potential $414 million five-year revenue opportunity for Callan JMB while helping establish a next-generation pharmaceutical manufacturing ecosystem in the United States.
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.